Patient P-01825

Synthetic patientNBL-101 · Day 100 · 35–44 · F · baseline S20Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Favorable

GI state

Improving

Inflammatory state

Improving

Nutritional resilience

Improving

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S20

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability-20
Inflammatory activity-15
Nutritional resilience+7
Treatment adherence-4

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

0.3/100

improving · -2.1 vs previous 14 d

Toxicity

Blood

8.5/100

stable · -0.4 vs previous 14 d

Sleep quality

Wearable

45.7/100

stable · -1.1 vs previous 14 d

Energy level

Daily log

7.6/10

stable · -0.1 vs previous 14 d

Stress level

Daily log

3.8/10

stable · -0.2 vs previous 14 d

Steps

Wearable

6,677

stable · +0 vs previous 14 d

Adherence

Companion

91.3 %

stable · +2.3 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards restoration · 110 from the failing basin, 26 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

HY-01 Hydration Protocol
only 44% improved among 9 similar

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Spicy / capsaicin
-2.3no signal · 41%
Simple carbohydrates
-1.3no signal · 37%
Dietary fat load
+0.9no signal · 20%
Alcohol
+0.4no signal · 15%
Histamine load
+0.1no signal · 15%
Insoluble fibre
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↓35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 36 ms, trending down
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure

Microbiome

Shannon diversity 3.5 · butyrate capacity 52/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 34 ms
Sleep: 6.3 h
Steps: 5,204
Resting HR: 67 bpm

Daily log: GI score 0, nutritional resilience 73, adherence 91.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01654	48%	S08	CR-01	improved	85
P-01796	47%	S09	SC-12	improved	86
P-01495	46%	S07	BR-03	improved	85
P-01791	44%	S06	ME-01	improved	79
P-01798	39%	S08	NP-02	improved	78
P-01439	37%	S18	ME-01	improved	79
P-01467	37%	S09	HY-01	improved	79
P-01625	37%	S06	SC-12	improved	83
P-01329	36%	S08	BR-03	improved	79
P-01671	36%	S04	SC-12	improved	90
P-01479	35%	S15	DT-01	improved	84
P-01503	31%	S15	ME-01	improved	80